Walleye Trading LLC Bluebird Bio, Inc. Put Options Transaction History

Walleye Trading LLC

16 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $47,414 - $124,122	15,100 New	15,100 $48,000
Q2 2022 Aug 08, 2022	SELL	$2.94 - $5.23 $11,466 - $20,397	-3,900 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $84,656 - $220,480	-20,800 Reduced 84.21%	3,900 $19,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $190,848 - $347,403	-21,300 Reduced 46.3%	24,700 $247,000
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $515,916 - $963,900	45,900 Added 45900.0%	46,000 $879,000
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $9,020 - $11,045	-500 Reduced 83.33%	100 $3,000
Q1 2021 May 17, 2021	BUY	$16.59 - $33.89 $9,954 - $20,334	600 New	600 $18,000
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $71,500 - $98,592	-2,600 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $65,435 - $83,125	-1,900 Reduced 42.22%	2,600 $140,000
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $54,240 - $91,940	2,000 Added 80.0%	4,500 $275,000
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $604,296 - $1.47 Million	-23,100 Reduced 90.23%	2,500 $115,000
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $159,664 - $209,678	3,400 Added 15.32%	25,600 $2.25 Million
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $1.16 Million - $1.82 Million	19,500 Added 722.22%	22,200 $2.04 Million
Q2 2019 Aug 14, 2019	SELL	$75.84 - $105.21 $15,168 - $21,042	-200 Reduced 6.9%	2,700 $343,000
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $96,660 - $156,165	1,500 Added 107.14%	2,900 $456,000
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $82,740 - $130,564	1,400 New	1,400 $139,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.